Noscapine Inhibits Human Prostate Cancer Progression and Metastasis in a Mouse ModelBARKEN, Israel; GELLER, Jack; ROGOSNITZKY, Moshe et al.Anticancer research. 2008, Vol 28, Num 6A, pp 3701-3704, issn 0250-7005, 4 p.Article

Prophylactic Noscapine Therapy Inhibits Human Prostate Cancer Progression and Metastasis in a Mouse ModelBARKEN, Israel; GELLER, Jack; ROGOSNITZKY, Moshe et al.Anticancer research. 2010, Vol 30, Num 2, pp 399-401, issn 0250-7005, 3 p.Article

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasiaLOWE, Franklin C; MCCONNELL, John D; BRUSKEWITZ, Reginald C et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 4, pp 791-796, issn 0090-4295, 6 p.Article

The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse modelMENG YANG; BURTON, Doug W; GELLER, Jack et al.Clinical cancer research. 2006, Vol 12, Num 8, pp 2602-2606, issn 1078-0432, 5 p.Article

The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trialMATSUMOTO, Alvin M; TENOVER, Lisa; ZHANG, Gang K et al.The Journal of urology. 2002, Vol 167, Num 5, pp 2105-2108, issn 0022-5347Article

Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent proteinYANG, Meng; JIANG, Ping; YAMAMOTO, Norio et al.The Prostate. 2005, Vol 62, Num 4, pp 374-379, issn 0270-4137, 6 p.Article

The effect of finasteride in men with benign prostatic hyperplasia. CommentaryGORMLEY, Gleen J; STONER, Elizabeth; VAUGHAN, E. Darracott et al.The Journal of urology. 2002, Vol 167, Num 2, pp 1102-1108, issn 0022-5347, 2Article